9-valent HPV vaccine study
Part of Cancer, Immune system & allergy, Women’s health & pregnancy clinical trials.
This study looks at the safety and immune response of a 9-valent HPV vaccine. It is for women who have already received a full course of certain HPV vaccines and are now getting a different one to see if it boosts their immunity.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 to 45 years old.
- You have completed the full three-dose series of one of these HPV vaccines: Cecolin (XinKeNing), Cervarix (XiRuiShi), or Walvax (WoZeHui).
- Your last dose of that HPV vaccine was at least 12 months ago.
- You are not pregnant and are willing to use effective birth control for 8 months after your first study dose (or have had certain surgeries to prevent pregnancy).
- You have not had any other HPV vaccine besides those three.
- You are generally healthy, without serious medical conditions, severe allergies, unstable asthma, bleeding disorders, or epilepsy (with exceptions).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a 9-type HPV vaccine to see how well it works, how it helps the body build protection, and whether it’s safe. It’s for healthy Chinese women who have not had HPV vaccination before and meet specific health and timing requirements.
This trial tests whether different batches of the HPV 9-valent vaccine work consistently. It's for Chinese women aged 18 to 30 who have not had any HPV vaccine or abnormal cervical screening results.
This trial tests an 11-type HPV vaccine to prevent infection from multiple HPV strains. If you enroll, you’ll receive scheduled vaccine doses and have health and gynecologic check-ins to see how well the vaccine works and is tolerated.
This Phase 4 study tests whether a 9-type HPV vaccine (9vHPV) can reduce how infectious HPV is and lower the chance of HPV spreading in women who already have HPV16 and/or HPV18. It focuses on specific HPV-positive women recently diagnosed and compares what happens after vaccination.
This trial tests a new 15-valent HPV vaccine to see if it is safe and creates a strong immune response. If you are between 9 and 45 years old and have not had an HPV vaccine before, you may be able to join.
This study looks at how well the HPV vaccine works in women who have already been exposed to the virus through sexual activity. It aims to understand the immune response and potentially improve protection against HPV-related cancers.
Hear when a new Cervical Cancer Prevention trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.